A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...

Bentracimab was developed specifically to reverse ticagrelor's antiplatelet effects and restore platelets' normal ability to form blood clots and stop bleeding.

Please provide your email address to receive an email when new articles are posted on . Bentracimab restored platelet function in patients on ticagrelor with major bleeding or undergoing urgent ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients undergoing urgent surgery or experiencing major ...